Clinical Trial

LDLT in Non Resectable Colo-rectal Cancer Liver Metastasis

Study acronym: LIVERMORE
Recruiting
View on ClinicalTrials.gov →
Summary
This study is an interventional open label prospective study that aims to assess both overall and disease-free survival of patients treated with LDLT, partial or whole graft LT from deceased donors for unresectable CRLM. Secondary outcomes are graft survival and donor outcomes in terms of safety and quality of life. Donor selection is performed according to the currently used Institutional and National standards and protocols.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2022-01-06; most recent amendment 2025-09-20.
Trial Details
NCT Number NCT05186116
Lead Sponsor Azienda Ospedaliero-Universitaria di Modena
Conditions Colon Adenocarcinoma, Liver Metastasis Colon Cancer
Enrollment 25 participants
Start Date 2022-01-01
Primary Completion 2027-01-01 (estimated)
Study Completion 2032-01-01 (estimated)
Updated on ClinicalTrials.gov 2025-09-25